Fagron SA header image

Fagron SA

FAGR

Equity

ISIN BE0003874915 / Valor 3425437

Euronext - Euronext Brussels (2026-05-06)
EUR 24.85+0.81%

Fagron SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Fagron SA is a prominent player in the pharmaceutical industry, specializing in pharmaceutical compounding, which involves creating personalized medication solutions tailored to individual patient needs. The company operates in a knowledge-intensive niche market, focusing on enhancing personalized medicine by collaborating closely with prescribers and pharmacists. Fagron's global initiative, Formulary, provides a wide array of customized formulas that cater to specific medical indications, thereby supporting healthcare professionals in delivering tailored treatment options. Additionally, Fagron emphasizes education and training through its Fagron Academies, which are established in various countries to inform and train healthcare providers about the intricacies of compounding. This strategic approach underscores Fagron's commitment to improving patient health outcomes by making personalized medicine more accessible.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

17.2%1Y
46.8%3Y
32.4%5Y

Performance

19.1%1Y
19.9%3Y
24.3%5Y

Volatility

Market cap

2142 M

Market cap (USD)

Daily traded volume (Shares)

97,488

Daily traded volume (Shares)

1 day high/low

16.76 / 16.58

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%USD 43.76
Udemy Inc
Udemy Inc Udemy Inc Valor: 114176816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.27%USD 4.80
elf Beauty Inc
elf Beauty Inc elf Beauty Inc Valor: 33775016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.38%USD 61.43
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.18%USD 23.90
BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.00%USD 68.09
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.11%USD 232.55
Janux Therapeutics Inc
Janux Therapeutics Inc Janux Therapeutics Inc Valor: 111742522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.02%USD 14.62
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.82%USD 70.99
Curatis Holding Ltd
Curatis Holding Ltd Curatis Holding Ltd Valor: 133078097
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.44%CHF 22.70
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1103058
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.58%GBP 11.18